Biblio
Pluripotent stem cell-based cardiac regenerative therapy for heart failure. J Mol Cell Cardiol. 2024;187:90-100.
. Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review. J Card Fail. 2023;29(4):503-513.
. Hydrogel-Sheathed Hipsc-Derived Heart Microtissue Enables Anchor-Free Contractile Force Measurement. Adv Sci (Weinh). 2023:e2301831.
Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin. Stem Cell Res Ther. 2023;14(1):240.
Metabolism-based cardiomyocytes production for regenerative therapy. J Mol Cell Cardiol. 2023.
. Scalable production of homogeneous cardiac organoids derived from human pluripotent stem cells. Cell Rep Methods. 2023;3(12):100666.
.
.
Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels. FEBS Open Bio. 2015;5:219-25.
Distinct iPS Cells Show Different Cardiac Differentiation Efficiency. Stem Cells Int. 2013;2013:659739.